Over Active Bladder
Pipeline by Development Stage
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (13)
Total enrollment: 5,339 patients across 13 trials
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Fesoterodine "add-on" Male Overactive Bladder Study
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects
A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
BlueWind Medical System for the Treatment of Patients With OAB
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.